Guillain–Barré syndrome: rare extra-intestinal manifestation of hepatitis B
- 80 Downloads
Extrahepatic syndromes are uncommon manifestations of acute and chronic hepatitis B. The pathogenesis likely involves an aberrant immunologic response to extrahepatic viral proteins. Antiviral therapy reduces the availability of these viral protein antigens and thus halts immune activation. Approximately 1% of all cases of acute inflammatory demyelinating polyneuropathy are associated with hepatitis B. Guillain–Barre syndrome (GBS) is a remarkably clinically diverse disorder with distinctive variants characterised by an immune-mediated attack to components of the peripheral nervous system. In this report, we present a rare case of GBS with chronic hepatitis B that resolved with antiviral and intravenous immunoglobulin therapy.
KeywordsGuillain–Barré syndrome Hepatitis B Extrahepatic syndrome
Compliance with ethical standards
Conflict of interest
Dr. Amey Sonavane, Dr. Sanjiv Saigal, Dr. Abhishek Kathuria, Dr. Narendra Singh Choudhary, Dr. Neeraj Saraf have no conflict of interest.
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent was obtained from the patient for being included in the study.
- 5.Souayah N, Nasar A, Suri MF, Qureshi AI. Guillain-Barré syndrome after vaccination in United States: data from the centers for disease control and prevention/food and drug administration vaccine adverse event reporting system (1990–2005). J Clin Neuromuscul Dis. 2009;11(1):1–6.CrossRefPubMedGoogle Scholar
- 11.Yimam KK, Merriman RB, Frederick RT. A rare case of acute hepatitis B virus infection causing Guillain-Barré syndrome. Gastroenterol Hepatol. 2013;9:121–3.Google Scholar